GSK (GlaxoSmithKline) Logo

GSK (GlaxoSmithKline)

🇬🇧
GSK
GB00BN7SWP63

GSK is a leading global British healthcare company focused on developing innovative vaccines and specialty medicines. With a clear emphasis on immunology and genetics, GSK researches solutions for infectious diseases and cancer to improve the quality of life for patients worldwide.

Next Quarterly Earnings

Wednesday, October 28, 2026
CW 44
Pre-Market
In 62 days
Confirmed by the company

Date confirmed from the company's own financial calendar.

Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

Quiet period starts on September 30, 2026

Stock Price

Frequently asked questions

When will GSK (GlaxoSmithKline) report its next quarterly earnings?

GSK (GlaxoSmithKline) is scheduled to report its next quarterly earnings on 10/28/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

When did GSK (GlaxoSmithKline) last report quarterly earnings?

GSK (GlaxoSmithKline) last reported quarterly earnings on 7/28/2026 (Q2 2026). Earnings per share (EPS) came in at 0.51 GBP.

How does GSK (GlaxoSmithKline) stock react to earnings?

Across its last 5 earnings reports, GSK (GlaxoSmithKline) stock moved by ±6% on average the following day. The largest reaction was +7.6% on 02/05/2025; 4 of 5 reactions were positive.

How often has GSK (GlaxoSmithKline) beaten expectations?

GSK (GlaxoSmithKline) has beaten analyst EPS estimates in 5 of its last 5 evaluated quarters (beat rate: 100%).

How do I add the GSK (GlaxoSmithKline) earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:£0.52
Actual:
Q2 2026
Beat
Estimate:£0.46
Actual:£0.51
Difference:+£0.04
Price reaction (1 day):+3.5 %
Price reaction (7 days):-2.4 %
Q1 2026
Beat
Estimate:£0.43
Actual:£0.47
Difference:+£0.03
Price reaction (1 day):-5.4 %
Price reaction (7 days):-7.5 %
Q4 2025
Beat
Estimate:£0.24
Actual:£0.26
Difference:+£0.02
Price reaction (1 day):+6.9 %
Price reaction (7 days):+10.5 %
Q3 2025
Beat
Estimate:$0.47
Actual:$0.55
Difference:+$0.08
Price reaction (1 day):+6.6 %
Price reaction (7 days):+8.8 %
Q1 2025
Beat
Estimate:$0.42
Actual:$0.47
Difference:+$0.04
Q4 2024
Estimate:
Actual:
Price reaction (1 day):+7.6 %
Price reaction (7 days):+4.7 %

Earnings statistics

Stock reaction to earnings

±6%
Avg. next-day move
+7.6%
Largest move (02/05/2025)
80%
Share of positive reactions
±6.8%
Avg. move after 7 days

Basis: price reactions to the last 5 report dates (close to close).

Estimates vs. results

5/5
Quarters above estimates
100%
Beat rate
+4.8%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
GSK (GlaxoSmithKline)
Ticker Symbol
GSK
ISIN
GB00BN7SWP63
Country
🇬🇧
UK
Sector